These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 18250952

  • 1. Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398.
    Lane EL, Cheetham S, Jenner P.
    J Neural Transm (Vienna); 2008; 115(3):423-9. PubMed ID: 18250952
    [Abstract] [Full Text] [Related]

  • 2. Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours.
    Lane EL, Cheetham SC, Jenner P.
    Eur J Neurosci; 2005 Jan; 21(1):179-86. PubMed ID: 15654855
    [Abstract] [Full Text] [Related]

  • 3. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
    Ravenscroft P, Chalon S, Brotchie JM, Crossman AR.
    Exp Neurol; 2004 Jan; 185(1):36-46. PubMed ID: 14697317
    [Abstract] [Full Text] [Related]

  • 4. Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?
    Lane EL, Cheetham SC, Jenner P.
    Exp Neurol; 2006 Feb; 197(2):284-90. PubMed ID: 16005456
    [Abstract] [Full Text] [Related]

  • 5. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 6. Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats.
    Bové J, Serrats J, Mengod G, Cortés R, Aguilar E, Marin C.
    Synapse; 2006 Jun 01; 59(7):435-44. PubMed ID: 16498608
    [Abstract] [Full Text] [Related]

  • 7. Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.
    Tel BC, Zeng BY, Cannizzaro C, Pearce RK, Rose S, Jenner P.
    Neuroscience; 2002 Jun 01; 115(4):1047-58. PubMed ID: 12453478
    [Abstract] [Full Text] [Related]

  • 8. Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.
    Glavan G.
    Brain Res; 2008 Oct 21; 1236():216-24. PubMed ID: 18721798
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.
    Ko WK, Martin-Negrier ML, Bezard E, Crossman AR, Ravenscroft P.
    Neurobiol Dis; 2014 Oct 21; 70():138-48. PubMed ID: 24969021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
    Winkler C, Kirik D, Björklund A, Cenci MA.
    Neurobiol Dis; 2002 Jul 21; 10(2):165-86. PubMed ID: 12127155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Denervation and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats.
    St-Hilaire M, Landry E, Lévesque D, Rouillard C.
    Neurobiol Dis; 2003 Oct 21; 14(1):98-109. PubMed ID: 13678671
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression.
    Duty S, Brotchie JM.
    Exp Neurol; 1997 Apr 21; 144(2):423-32. PubMed ID: 9168843
    [Abstract] [Full Text] [Related]

  • 18. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
    Périer C, Marin C, Jimenez A, Bonastre M, Tolosa E, Hirsch EC.
    J Neurochem; 2003 Sep 21; 86(6):1328-37. PubMed ID: 12950442
    [Abstract] [Full Text] [Related]

  • 19. AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.
    Périer C, Marin C, Bonastre M, Tolosa E, Hirsch EC.
    Eur J Neurosci; 2002 Dec 21; 16(11):2236-40. PubMed ID: 12473092
    [Abstract] [Full Text] [Related]

  • 20. Effect of repeated administration of dopamine agonists on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion.
    Granata R, Wenning GK, Jolkkonen J, Jenner P, Marsden CD.
    J Neural Transm (Vienna); 1996 Dec 21; 103(3):249-60. PubMed ID: 8739837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.